News about "oncology clinical trials"

IMUNON Reports Phase 2 Data Showing Improved Survival in Advanced Ovarian Cancer

IMUNON Reports Phase 2 Data Showing Improved Survival in Advanced Ovarian Cancer

IMUNON reports updated Phase 2 data showing improved Overall Survival (OS) with IMNN-001 in advanced ovarian cancer.

Oncology Clinical Trials | 26/03/2026 | By News Bureau

MMS Holdings, Friends of Cancer Research Partner to Develop Decision Frameworks for Interim Survival Data in Oncology Trials

MMS Holdings, Friends of Cancer Research Partner to Develop Decision Frameworks for Interim Survival Data in Oncology Trials

MMS Holdings (MMS) has been selected by Friends of Cancer Research (Friends) to support the development of practical decision frameworks to inform the interpretation of interim overall survival (OS) data in oncology clinical trials.

Oncology Clinical Trials | 20/08/2025 | By Dineshwori 196


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members